GL1X · GenesisL1 explorer

MolNFT v1 · #164985 · protein

Btk in complex with LOU064, a potent and highly selective covalent inhibitor

6TFP: “Btk in complex with LOU064, a potent and highly selective covalent inhibitor”. X-ray diffraction, 2 ligands (N6Z, NA). MolNFT v1 #164985 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6TFP
Type
protein
Length
1,335 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q06187
Ligands
N6Z, NA

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein266—Q06187
B—protein275—Q06187
C, E—protein264—Q06187
D—protein266—Q06187

Ligands and binding sites

  • N6Z · ~{N}-[3-[6-azanyl-5-[2-[methyl(propanoyl) amino]ethoxy]pyrimidin-4-yl]-5-fluoranyl-2-methyl-phenyl]-4-cyclopropyl-2-fluoranyl-benzamide · ligand · 5 copies · chains A, B, C, D, E
  • NA · Sodium ion · metal · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6TFP · BTK in complex with LOU064, a potent and highly selective covalent inhibitor · the same entry in another collection · chain E against E, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.